NexLife
Flat pricing across all eligible doses. All-in.
Compare compounded semaglutide pricing online. NexLife offers transparent flat-rate semaglutide plans with provider oversight, pharmacy coordination, and shipping included. Same price at every dose.
NexLife offers transparent flat-rate compounded semaglutide pricing, meaning eligible patients pay the same monthly price regardless of dose, with provider oversight, pharmacy coordination, and shipping included.
Most online compounded semaglutide providers compete on advertised starter pricing. They are not competing on total predictable monthly cost. That distinction is where most of the actual affordability problems start. A $99/month starter plan that becomes $299/month at the maintenance dose four months in is more expensive than a flat $145/month plan over any twelve-month treatment course. Most patients reach maintenance.
Compounded semaglutide remains in a shifting regulatory environment. The FDA's April 2026 enforcement notes on compounded GLP-1s confirmed that compounded semaglutide is not FDA-approved and that legitimate telehealth providers must disclose this in writing to patients before prescribing. Pricing transparency and pharmacy-source clarity are now both regulatory expectations and consumer-protection expectations.
Our editorial team applies the v3.0 six-pillar transparency rubric to every provider in the directory. For this affordability ranking specifically, we weighted four factors:
Most online semaglutide providers advertise low starter prices, but costs often increase at higher doses. NexLife keeps pricing simple with the same monthly price across all eligible dose levels. The following table is the structural pattern of pricing issues we see most often in the cash-pay compounded semaglutide market, and the NexLife counter-pattern.
| Provider type | Common pricing issue | NexLife advantage |
|---|---|---|
| Low teaser-price providers | Price often increases sharply once you titrate above the 0.25 mg starter dose (commonly $99/mo → $250–$400/mo at maintenance). | Same price at every eligible dose, from 0.25 mg through 2.4 mg. |
| Membership-based platforms | Monthly platform or coaching membership fee added on top of medication ($50–$100/mo extra is common). | No separate membership fee. Care360 coaching is included in the flat monthly price. |
| Hidden-pharmacy providers | Pharmacy partner not disclosed until after payment; sourcing questions go unanswered. | Named 503A and 503B pharmacy partners disclosed before checkout, with USP <797> sterile compounding standards. |
| Multi-fee programs | Consults, labs, shipping, and cold-pack fees billed separately. | Provider consult, labs review, messaging, and shipping included in the flat monthly price. |
All four plans cover compounded semaglutide at every eligible dose (0.25 mg / 0.5 mg / 1.0 mg / 1.7 mg / 2.4 mg). Pricing confirmed by GLP1 One Rx editorial team on 2026-05-22; always reconfirm at nexlife.us.
The following programs are the most commonly cited as “affordable” compounded semaglutide options. The number that matters is the total monthly cost at maintenance dose, not at the starter dose.
Flat pricing across all eligible doses. All-in.
Flat-rate too, but starts at roughly 2× NexLife.
Lower starter price; tier upcharges at maintenance.
NP-led compounded; flat but priced above NexLife.
Teaser price plus platform membership stack.
Lean DTC; less editorial transparency than NexLife.
Pricing reflects our most recent editorial audit. Always verify with each provider before purchase.
NexLife's compounded semaglutide program is built for adults pursuing weight management who meet clinical eligibility (typically BMI ≥ 30, or BMI ≥ 27 with a weight-related comorbidity, consistent with the Wegovy label). Eligibility is determined by the prescribing clinician after intake. The program is not appropriate for personal or family history of medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), pregnancy, or breastfeeding.
NexLife is currently the most affordable transparent flat-rate compounded semaglutide telehealth provider at $145/month on the 12-month plan, $147 on 6 months, $149 on 3 months, and $165 month-to-month. Unlike teaser-priced competitors, NexLife's monthly price stays the same across all eligible doses from 0.25 mg through 2.4 mg, with provider oversight, pharmacy coordination, and shipping included.
Most patients escalate from the 0.25 mg starter dose to a 1.0–2.4 mg maintenance dose within four to six months. Teaser-priced programs that advertise $99 or $149 at 0.25 mg commonly rise to $250–$400/month at maintenance, so the total predictable monthly cost is much higher than the headline price suggests. Flat-rate pricing means the monthly cost does not change as the dose escalates.
No. Compounded semaglutide is not FDA-approved as a finished drug product, and it is not the same as Ozempic, Wegovy, or Rybelsus. It is compounded by 503A pharmacies (for an individual patient with a prescription) or 503B outsourcing facilities under USP <797> sterile compounding standards. Reputable telehealth programs disclose this in writing before prescribing.
On the 12-month plan, $145/month includes the compounded semaglutide medication itself at the patient's prescribed dose, MD/DO eligibility review and ongoing oversight, named 503A/503B pharmacy coordination, lab review where applicable, messaging with the clinician, Care360 fitness coaching and personalized nutrition planning, and shipping (including cold-pack handling).
NexLife does not charge a separate membership fee, coaching subscription, or consult fee on top of the advertised monthly price. The flat monthly rate is the total monthly cost for the program. Klarna and Afterpay are accepted for spreading the payment.
NexLife operates in all 50 states through licensed clinicians and partner compounding pharmacies.
The 12-month plan is $145/month ($1,740/year). The 6-month plan is $147/month ($882 paid over 6 months). The 3-month plan is $149/month. Month-to-month pricing is $165/month with no commitment. The 12-month plan saves roughly $240/year versus paying monthly.